Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-α-induced injury

Endocrinology

Volumn 140, Issue 7, 1999, Pages 3063-3072

  Ye, P ^a   D'Ercole, A J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN; MESSENGER RNA; MYELIN BASIC PROTEIN; PROTEOLIPID PROTEIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DEMYELINATING DISEASE; DOSE RESPONSE; DRUG INDUCED DISEASE; GENE EXPRESSION REGULATION; GENE NUMBER; MOUSE; MYELINATION; NEUROTOXICITY; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; STEM CELL; TIME;

EID: 0033305581     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.7.6754     Document Type: Article

References (46)

1. Experimental autoimmune encephalomyelitis: Immunotherapy with anti-tumor necrosis factor antobodies and soluble tumor necrosis factor receptors
2. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro
3. Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury
4. ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor
5. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death
6. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor α
7. Astrocyte-specific but not neuron-specific transmenbrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice
8. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy
9. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system
10. Tumor necrosis factor α and lymphotoxin α are not required for induction of acute experimental autoimmune encephalomyelitis
11. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
12. Challenging cytokine redundancy: Inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice
13. Insulin-like growth factor I mRNA levels are developmentally regulated in specific regions of the rat brain
14. Localization of insulin-like growth factor-1 mRNA in murine central nervous system during postnatal development
15. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice
16. Insulin-like growth factor-I influences the initiation of myelination: Studies of the anterior commissure of transgenic mice
17. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis
18. Cryogenic spinal cord injury induces astrocytic gene expression of insulin-like growth factor I and insulin-like growth factor binding protein 2 during myelin regeneration
19. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination
20. Induction of tumor necrosis factor-α in the mouse hippocampus following transient forebrain ischemia
21. Cell death and control of cell survival in the oligodendrocyte lineage
22. Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue
23. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis
24. Astroglia in culture
25. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol·chloroform extraction
26. Aberrant splicing of proteolipid protein mRNA in the dysmyelinating jimpy mutant mouse
27. Identification of a cDNA coding for a fifth form of myelin basic protein in mouse
28. p1B15: A cDNA clone of the rat mRNA encoding cyclophilin
29. Cyclic AMP-induced upregulation of proteolipid protein and myelin associated glycoprotein gene expression in C6 cells
30. O-2A progenitors of the mouse optic nerve exhibit a developmental pattern of antigen expression different from the rat
31. Expression of cell surface markers and myelin proteins in cultured oligodendrocytes from neonatal brain of rat and mouse: A comparative study
32. Distribution of proteolipid protein and myelin basic protein in cultured mouse oligodendrocytes: Primary vs. secondary cultures
33. Insulin-like growth factor I/somatomedin C: A potent inducer of oligodendrocyte development
34. Insulin-like growth factor I stimulates oligodendrocyte development and myelination in rat brain aggregate cultures
35. Effects of interleukin-1 and tumor necrosis factor-α on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro
36. Functions of ceramide in coordinating cellular responses to stress
37. Targeted CNS expression of interferon- in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development
38. Insulin-like growth factor I promotes cell proliferation and oligodendroglial commitment in rat glial progenitor cells developing in vitro
39. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice
40. Reversible inhibitory effects of interferon-γ and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro
41. Synergistic differentiation-promoting activity of interferon γ and tumor necrosis factor-α: Role of receptor regulation on human neuroblasts
42. Tumor necrosis factor-α (TNF-α), interferon-γ, and interleukin-6 but not TNF-β induce differentiation of neuroblastoma cells: The role of nitric oxide
43. Insulin-like growth factor 1 treatment reduces clinic deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis
44. Expression of IGF-I and insulin receptor genes in the rat central nervous system: A developmental, regional, and cellular analysis
45. Insulin-like growth factor I (IGF-I) receptors and IGF-I action in oligodendrocytes from rat brains
46. Chronic relapsing experimental autoimmune encephalomyelitis: Effects of insulin-like growth factor-I treatment on clinical deficits, lesion severity, glial responses, and blood brain barrier defects